Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Improving Inhaled Corticosteroid Prescribing Practices for Children Admitted With an Asthma Exacerbation.

Created on 16 Nov 2026

Authors

Zenna Solomon, Kalliope Tsirilakis

Published in

Pediatric pulmonology. Volume 61. Issue 11.

Abstract

Asthma management guidelines recommend inhaled corticosteroids (ICS), including as-needed use, to treat airway inflammation, reduce bronchial hyperresponsiveness, and thereby lower the risk of severe exacerbations. Our objective was to achieve a 90% inpatient ICS initiation rate for children hospitalized with an acute asthma exacerbation over a 12-month period. We focused our initiative on hospitalized children to target those at greatest risk of asthma-related morbidity.
The Model for Improvement was used to define study aims/measures and create a key driver diagram to guide intervention design. Interventions focused on enhancing ICS access, standardizing workflow, healthcare provider asthma education, and integrating clinical decision support into the electronic health record. We performed serial planned experimentation to test interventions using Plan-Do-Study-Act (PDSA) cycles. Shewhart P-charts and established rules for detecting special cause variation were used to analyze data. Our outcome measure was ICS initiation rate during inpatient hospitalization among children discharged on ICS therapy. Process measures were the percentage of children for whom asthma severity was assessed on admission, and the percentage of children continued on home ICS therapy during admission. The balancing measure was length of stay.
The percentage of children initiated on ICS therapy during admission increased from 16% to 80% over a 12-month period with further improvement reaching 94% 1-year post-intervention. There was no change in length of stay.
The availability of a pediatric-appropriate ICS on hospital medication formulary and the initiation of an asthma clinical management pathway were the most impactful interventions to improve ICS prescription for children admitted with an asthma exacerbation.

PMID:
43037176
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement